Pulmatrix Inc.

Pulmatrix Inc. company information, Employees & Contact Information

Explore related pages

Pulmatrix Inc. email format Pulmatrix Inc. management contacts

Related company profiles:

PULMATRIX is committed to the development and commercialization of novel and transformational medicines for patients all over the world, using our proprietary iSPERSE™ technology to optimally deliver both respiratory and non-respiratory therapies via the respiratory system.

Company Details

Employees
17
Address
36 Crosby Dr, Bedford,massachusetts 01730,united States
Phone
(781)357-2399
Email
in****@****rix.com
Industry
Biotechnology
Website
pulmatrix.com
HQ
Bedford, Massachusetts
Competitors
Jasper Therapeutics, Exicure, Rezolute, Inc., ASP Isotopes, Monopar Therapeutics Inc., Cullgen Inc., Entera Bio Ltd., Bright Minds Biosciences, Eton Pharmaceuticals, Benitec Biopharma Inc..
Looking for a particular Pulmatrix Inc. employee's phone or email?

Pulmatrix Inc. Questions

News

Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets - PR Newswire

Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets PR Newswire

Pulmatrix to Divest Migraine Drug PUR3100 as Cullgen Merger Approaches: Q1 Earnings Detail Strategic Shift - Stock Titan

Pulmatrix to Divest Migraine Drug PUR3100 as Cullgen Merger Approaches: Q1 Earnings Detail Strategic Shift Stock Titan

Pulmatrix Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for Assets - PR Newswire

Pulmatrix Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for Assets PR Newswire

Pulmatrix Announces Divestment Plan for Assets - citybiz

Pulmatrix Announces Divestment Plan for Assets citybiz

Pulmatrix submits IND application for PUR3100 - Clinical Trials Arena

Pulmatrix submits IND application for PUR3100 Clinical Trials Arena

Pulmatrix Receives US Patent for Investigational COPD Therapy - respiratory-therapy.com

Pulmatrix Receives US Patent for Investigational COPD Therapy respiratory-therapy.com

Pulmatrix to Merge with Cullgen - Contract Pharma

Pulmatrix to Merge with Cullgen Contract Pharma

Pulmatrix and Cullgen Announce Strategic Merger Agreement - Nasdaq

Pulmatrix and Cullgen Announce Strategic Merger Agreement Nasdaq

Cullgen Entering Public Market with Pulmatrix Merger - San Diego Business Journal

Cullgen Entering Public Market with Pulmatrix Merger San Diego Business Journal

Pulmatrix Launches iSPERSE - respiratory-therapy.com

Pulmatrix Launches iSPERSE respiratory-therapy.com

Pulmatrix and Cullgen Announce Proposed Merger - PR Newswire

Pulmatrix and Cullgen Announce Proposed Merger PR Newswire

Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation - PR Newswire

Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation PR Newswire

Pulmatrix Announces Stopping the PUR1900 Phase 2B Study Patient Enrollment and Closing the Study, in Agreement With Partner Cipla, to Preserve Cash and Facilitate Pursuit of Strategic Alternatives - PR Newswire

Pulmatrix Announces Stopping the PUR1900 Phase 2B Study Patient Enrollment and Closing the Study, in Agreement With Partner Cipla, to Preserve Cash and Facilitate Pursuit of Strategic Alternatives PR Newswire

Pulmatrix Announces Kinase Inhibitor Licensing Agreement with Lung Cancer Initiative at Johnson & Johnson - PR Newswire

Pulmatrix Announces Kinase Inhibitor Licensing Agreement with Lung Cancer Initiative at Johnson & Johnson PR Newswire

Pulmatrix and Cipla Technologies LLC enter into Definitive Agreement for the Development and Commercialization of Pulmazole™ - PR Newswire

Pulmatrix and Cipla Technologies LLC enter into Definitive Agreement for the Development and Commercialization of Pulmazole™ PR Newswire

Pulmatrix Stockholders Approve Merger with Cullgen - TipRanks

Pulmatrix Stockholders Approve Merger with Cullgen TipRanks

Pulmatrix Reports Q3 2025 Results and Strategic Shift - TipRanks

Pulmatrix Reports Q3 2025 Results and Strategic Shift TipRanks

Pulmatrix shuts down study, explores sale - The Business Journals

Pulmatrix shuts down study, explores sale The Business Journals

Will Pulmatrix Inc. stock return to pre crisis levels - July 2025 Movers & Weekly Chart Analysis and Trade Guides - Trung tâm Dự báo KTTV quốc gia

Will Pulmatrix Inc. stock return to pre crisis levels - July 2025 Movers & Weekly Chart Analysis and Trade Guides Trung tâm Dự báo KTTV quốc gia

Pulmatrix completes patient dosing for inhaled migraine treatment - Drug Delivery Business

Pulmatrix completes patient dosing for inhaled migraine treatment Drug Delivery Business

Dow Update: Is Pulmatrix Inc. stock positioned for digital transformation - Layoff News & Free Accurate Trade Setup Notifications - Trung tâm Dự báo KTTV quốc gia

Dow Update: Is Pulmatrix Inc. stock positioned for digital transformation - Layoff News & Free Accurate Trade Setup Notifications Trung tâm Dự báo KTTV quốc gia

Pulmatrix Supports World Asthma Day 2023 - GuruFocus

Pulmatrix Supports World Asthma Day 2023 GuruFocus

Biopharma Pulmatrix's Q3 revenue drops to $0 as trial ends, plans asset divestment - TradingView

Biopharma Pulmatrix's Q3 revenue drops to $0 as trial ends, plans asset divestment TradingView

Pulmatrix, Inc. SEC 10-Q Report - TradingView

Pulmatrix, Inc. SEC 10-Q Report TradingView

Is Pulmatrix Inc. stock a good choice for value investors - July 2025 Catalysts & Low Risk High Reward Ideas - Fundação Cultural do Pará

Is Pulmatrix Inc. stock a good choice for value investors - July 2025 Catalysts & Low Risk High Reward Ideas Fundação Cultural do Pará

Inhaled New Drug Delivery for Lung Disease Patients is Revealed in Video by Pulmatrix - Cystic Fibrosis News Today

Inhaled New Drug Delivery for Lung Disease Patients is Revealed in Video by Pulmatrix Cystic Fibrosis News Today

Pulmatrix revises bylaws, changes voting standards By Investing.com - Investing.com UK

Pulmatrix revises bylaws, changes voting standards By Investing.com Investing.com UK

Advances in inhaled drug delivery: an interview with Dr Robert Clarke - News-Medical

Advances in inhaled drug delivery: an interview with Dr Robert Clarke News-Medical

PULM Stock Price and Chart — NASDAQ:PULM - TradingView

PULM Stock Price and Chart — NASDAQ:PULM TradingView

Novartis-backed Pulmatrix merges with Ruthigen - - Global Venturing

Novartis-backed Pulmatrix merges with Ruthigen - Global Venturing

The Future of Inhaled Medications and Inhalation Technology - Contract Pharma

The Future of Inhaled Medications and Inhalation Technology Contract Pharma

Companies like Pulmatrix Inc.

Entera Bio Ltd. logo - Similar company to Pulmatrix Inc.

Entera Bio Ltd.

20
Benitec Biopharma Inc. logo - Similar company to Pulmatrix Inc.

Benitec Biopharma Inc.

20
Jasper Therapeutics logo - Similar company to Pulmatrix Inc.

Jasper Therapeutics

67
Exicure logo - Similar company to Pulmatrix Inc.

Exicure

6
Cullgen Inc. logo - Similar company to Pulmatrix Inc.

Cullgen Inc.

30
ASP Isotopes logo - Similar company to Pulmatrix Inc.

Asp Isotopes

77
Bright Minds Biosciences logo - Similar company to Pulmatrix Inc.

Bright Minds Bioscie...

8
Rezolute, Inc. logo - Similar company to Pulmatrix Inc.

Rezolute, Inc.

75
Eton Pharmaceuticals logo - Similar company to Pulmatrix Inc.

Eton Pharmaceuticals

51
Monopar Therapeutics Inc. logo - Similar company to Pulmatrix Inc.

Monopar Therapeutics...

19

Top Pulmatrix Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant